Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV

HIV Infections Clinical Trial

— WISH  

Official title:

Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04505371
• Other study ID #: 1R01CA243907-01
• Status: Recruiting
• Phase: N/A
• Start date: June 4, 2021
• Est. completion date: August 31, 2025

Study information

• Verified date: September 2023
• Source: Seattle Institute for Biomedical and Clinical Research
• Contact: John Kundzins, BS
• Phone: (206) 268-5278
• Email: John.Kundzins[@]VA.gov
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project will compare the effectiveness of an HIV-specific comprehensive wellness intervention designed to have broad appeal to smokers living with HIV to the effectiveness of standard care services that include referral to the National VA Quitline and SmokefreeVET texting program. Participants in both arms will have access to pharmacotherapy available through their Veterans Affairs (VA) healthcare providers.

Description:

Tobacco use remains the leading preventable cause of death and illness in our society, and smoking rates are disproportionately high among people living with HIV. NCI, nicotine dependence researchers, and HIV clinicians have all called for research to evaluate targeted and tailored smoking cessation programs for smokers living with HIV (SLWH). Research suggests SLWH are largely unaware of the HIV-specific deleterious effects of smoking and often lack motivation and confidence in their ability to quit. For these reasons, we developed the Wellness Intervention for Smokers with HIV (WISH).

Similar to standard care cessation services available to Veterans, WISH is delivered remotely by mobile phone (voice and text message). The program is designed for all SLWH, regardless of their initial motivation to quit. WISH follows evidence-based, best practice guidelines for nicotine dependence treatment, but is innovative in its use of a more comprehensive wellness approach. That is, the intervention addresses both smoking and a number of other personally relevant health behaviors (such as treatment engagement, medication adherence, stress and mood management, social support, alcohol use, etc.), making it relevant and engaging to all SLWH, not just those ready to stop smoking. For those not yet ready to quit, WISH is designed to build and strengthen motivation and self-confidence for quitting, while smokers also work on other personal health goals.

Once ready to quit smoking, participants receive evidence-based cognitive-behavioral counseling and encouragement to access nicotine replacement therapy (NRT) or other appropriate pharmacotherapy through usual care VA procedures. Medications will not be prescribed or dispensed by the study, allowing use of these standard services to be compared across study groups.

In this two-group randomized trial, we will compare the effectiveness of WISH to standard care services offered through the National VA Quitline and the SmokefreeVET texting program (tobacco cessation services available to all Veterans). Participants in both study groups can receive phone/ text counseling and have access to pharmacotherapy through VA. Cessation services in both study groups will be provided and overseen by the non-VA sites that developed each program.

Smoking-related outcomes will include 7-day point prevalence smoking abstinence and presence of any 24-hour intentional quit attempts, prolonged abstinence, and change in cigarettes per day. We will measure change in smoking-related knowledge, motivation and behavioral skills, as well as intervention reach and implementation. We will also describe comorbidities and explore intervention impact on markers of immune status and mortality risk using clinical data resources available through the Veterans Aging Cohort Study (VACS).

If effective, WISH could meaningfully increase the reach of cessation services and reduce smoking among HIV+ Veterans nationwide. To support this goal, dissemination efforts are planned in Year 5 to share the WISH program with the National VA Quitline. Because VA is the largest U.S. provider of HIV care, this research has the potential for significant public health impact.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 226
• Est. completion date: August 31, 2025
• Est. primary completion date: August 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• In care in the VA

• HIV+ serostatus

• Currently smoking 5+ cigarettes daily

• Access to cell phone with text messaging capabilities

• English speaking

Exclusion Criteria:

• Psychosis, dementia or significant cognitive impairment documented in the EHR

• Documented or observed hearing or comprehension difficulties that would preclude participation in study telephone calls

• Currently receiving cessation counseling or using an FDA approved treatment to quit smoking

• Institutionalized/imprisoned

• Pregnant

Related Conditions & MeSH terms

• HIV Infections
• Smoking
• Smoking Cessation

Intervention

Behavioral:
• Wellness Intervention for Smokers with HIV
WISH is delivered remotely by mobile phone (voice and text message). WISH addresses both smoking and a number of other personally relevant health behaviors (such as treatment engagement, medication adherence, stress and mood management, social support, alcohol use, etc.), making it relevant and engaging to all, not just those ready to stop smoking. For those not yet ready to quit, WISH is designed to build and strengthen motivation and self-confidence for quitting, while smokers also work on other personal health goals. Once ready to quit smoking, participants receive evidence-based cognitive-behavioral counseling and encouragement to access nicotine replacement therapy (NRT) or other appropriate pharmacotherapy through usual care VA procedures. Medications will not be prescribed or dispensed by the study.

Locations

Country	Name	City	State
United States	VA Puget Sound Health Care System Seattle Division	Seattle	Washington

Sponsors (5)

Lead Sponsor	Collaborator
Seattle Institute for Biomedical and Clinical Research	Fred Hutchinson Cancer Center, Kaiser Permanente, University of California, Davis, US Department of Veterans Affairs

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	7-day point-prevalence abstinence (PPA)	Smoking abstinence at 6-month follow-up by self-report and biochemically confirmed via saliva cotinine for a small selected group of individuals. Cotinine levels < 10 ng/ml and a self-report of 7 day PPA will be required to be coded a nonsmoker.	6 months post-randomization
Primary	Any 24-hour intentional quit attempt	The primary outcome will be presence of an intentional quit attempt [yes/no] reported between randomization and 6 month follow-up. Quit attempts will be assessed at each follow-up.	3 and 6 months postrandomization
Secondary	Floating prolonged abstinence	A proxy for sustained abstinence appropriate for evaluating a motivational intervention, in which the start point floats based on one's actual quit date rather than a pre-determined quit date	3 and 6 months post-randomization
Secondary	7-day self-report point-prevalence abstinence (PPA)	Self-report of abstinence from smoking, even a puff	3 and 6 months post-randomization
Secondary	30-day self-report point-prevalence abstinence (PPA)	Self-report of abstinence from smoking, even a puff	3, 6, 12 months post-randomization
Secondary	Cigarettes smoked per day	Self-report; even a puff counts as smoking	3 and 6 months post-randomization
Secondary	HIV-specific smoking knowledge	Items validated in a survey of Smokers Living with HIV conducted by the study team during a study titled "Smoking cessation-related information, motivation, and behavioral skills specific to HIV-infected smokers" (likert scale)	3 and 6 months post-randomization
Secondary	Motivation to quit smoking	1-10 likert scale	3 and 6 months post-randomization
Secondary	Smoking cessation related to self-efficacy	1-10 likert scale on domains (each) of quitting smoking, reducing smoking, managing cravings, and stimulus control	3 and 6 months post-randomization
Secondary	Nicotine withdrawal symptom management (behavioral skills)	Self-report Minnesota Smoking Withdrawal Scale, Revised	3 and 6 months post-randomization
Secondary	Cessation medication use and adherence (behavioral skills)	Self-report and health records (pharmacy) monitoring	3 and 6 months post-randomization
Secondary	Absolute CD4 count	Lab value of CD4 ascertained via EHR	6 and 12 months post-randomization
Secondary	VACS index 2.0	Composite score based of various lab values ascertained via EHR	6 and 12 months post-randomization
Secondary	Intentional quit attempt frequency and duration	Behavioral Risk Factor Surveillance System (BRFSS)	3 and 6 months post-randomization